Terra Magnum Capital Partners: Funding, Team & Investors | Startup Intros

Loading organizations...

Terra Magnum Capital Partners: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Nov 10, 2025	Iambic Therapeutics	$100.0M Other Equity	—	Abingworth, Alexandria Venture Investments, Alumni Ventures, ARK Invest, Ascenta Capital, Catalio Capital Management, Everbright Biofund, Freeflow Ventures, Illumina Ventures, Pegasus Tech Ventures, Qatar Investment Authority, Regeneron Ventures, Sequoia Capital, Tao Capital Partners, Wilson Sonsini Goodrich & Rosati
Mar 27, 2023	ArriVent Biopharma	$155.0M Series B	Elena Viboch, James Healy	AIHC Capital, Catalio Capital Management, HBM Healthcare Investments, Hongshan Capital Group (Sequoia Capital China), Infinitum Asset Management, Lilly Asia Ventures, Octagon Capital, Carl Gordon, Shanghai Healthcare Capital, Sirona Capital, Unicorn Capital, Zoo Capital
Feb 16, 2022	Walking Fish Therapeutics, Inc.	$73.0M Series A	Manish Kothari, Daniel Janse	—
Oct 1, 2021	Structure Therapeutics	$100.0M Series B	Mark Nathan Lampert	Qiming Venture Partners, Casdin Capital, Cormorant Asset Management, Eight Roads Ventures, F-Prime Capital, Hongshan Capital Group (Sequoia Capital China), Janus Henderson Investors, Lilly Asia Ventures, Monashee Investment Management, Sage Partners, Schr"dinger, Stork Capital, Surveyor Capital, Chen Yu, TF Capital, Woodline Partners, WuXi AppTec
Jun 11, 2021	Senda Biosciences	$55.0M Series B Extension	—	Alexandria Venture Investments, Guillaume Pfefer, Longevity Vision Fund, Mayo Clinic, Mint Venture Partners, Partners Investment, Senda Biosciences, State of Michigan Retirement System
Apr 22, 2021	RNAimmune	$10.0M Seed	Hong Kong Hongrun, Smooth River	High Forest Investment, Walvax Biotechnology
Apr 1, 2021	Arcellx	$120.0M Series C	Samsara BioCapital, CAM Capital	Genoa Ventures, Adage, Asymmetry Ventures, CaaS Capital Management, Cambrian Biopharma, LG Tech, NEA, Novo Holdings, Sixty Degree Capital, SR One, Surveyor Capital, Suvretta Capital Management, Takeda Ventures
Aug 24, 2020	RNAimmune	$2.4M Seed	Terra Magnum Capital Partners	—
Apr 1, 2020	Erasca	$200.0M Series B	ARCH Venture Partners, Bihua Chen	Canaan Partners, SignalFire, City Hill Ventures, Colt Ventures, EDBI, Invus, LifeSci Venture Partners
Mar 18, 2020	Immunocore	$130.0M Series B	Rob Perez	Bill & Melinda Gates Foundation, CCB International, Eli Lilly and Company, JDRF T1D Fund, Rock Springs Capital, RTW Investments, WuXi AppTec
Jun 17, 2019	Viela Bio	$75.0M Series B	HBM Healthcare Investments	Barer & Son Capital, Cormorant Asset Management, Goldman Sachs, Temasek, Viking Global Investors
May 9, 2018	CStone Pharmaceuticals	$259.2M Series B	GIC	3W Partners, 6 Dimensions Capital, ARCH Venture Partners, AVICT Global, Boyu Capital, CPE, Hillhouse Capital, Hongshan Capital Group (Sequoia Capital China), King Star Capital, Taikang, WuXi Healthcare Ventures, Yunfeng Capital